New Stock News | Zhuozheng Medical's Hong Kong IPO Approved by the China Securities Regulatory Commission
On September 17, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice on the Filing for Overseas Issuance and Listing of Distinct Healthcare Holdings Limited." The company plans to issue no more than 6.371 million ordinary shares for overseas listing and list on the Hong Kong Stock Exchange. According to the prospectus, Distinct Healthcare was founded in 2012 and operates 20 medical service institutions across China, including 18 clinics and two hospitals, leveraging a centralized, standardized, and digital management system. The company has established a network covering some of China's most economically developed cities, including Shenzhen, Guangzhou, Beijing, Chengdu, Suzhou, Changsha, Shanghai, Chongqing, Hangzhou, and Wuhan. The company offers a wide range of medical services, such as general consultations, diagnostic and preventive medical services, treatment, and pharmaceutical sales. The company's revenue primarily comes from providing medical services through private medical service institutions and online medical service platforms, covering a range of specialties including pediatrics, dentistry, ophthalmology, dermatology, otolaryngology, surgery, gynecology, and internal medicine
